These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12669449)

  • 1. Model organisms and new tools: choose your weapons wisely.
    Ecker DJ; McAlpine J; Culver K
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):159-60. PubMed ID: 12669449
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural products in drug discovery.
    Harvey AL
    Drug Discov Today; 2008 Oct; 13(19-20):894-901. PubMed ID: 18691670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PK/PD modelling and simulations: utility in drug development.
    Rajman I
    Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Yeast Systems Biology Network: mating communities.
    Hohmann S
    Curr Opin Biotechnol; 2005 Jun; 16(3):356-60. PubMed ID: 15961037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of drug action: what does it take for success?
    Swinney DC
    Nat Rev Drug Discov; 2004 Sep; 3(9):801-8. PubMed ID: 15340390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trends in experimental pharmacology].
    Anichkov SV
    Vestn Akad Med Nauk SSSR; 1982; (5):3-9. PubMed ID: 6285631
    [No Abstract]   [Full Text] [Related]  

  • 7. In silico prediction of ADME properties: are we making progress?
    Beresford AP; Segall M; Tarbit MH
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and new fields in molecular pharmacology.
    Boutin JA
    Curr Opin Pharmacol; 2009 Oct; 9(5):577-9. PubMed ID: 19726229
    [No Abstract]   [Full Text] [Related]  

  • 9. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging applications of network and pathway analysis in drug discovery and development.
    Ganter B; Giroux CN
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):86-94. PubMed ID: 18175271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swarm chemistry.
    Sayama H
    Artif Life; 2009; 15(1):105-14. PubMed ID: 18855565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Silicon Cell initiative: working towards a detailed kinetic description at the cellular level.
    Snoep JL
    Curr Opin Biotechnol; 2005 Jun; 16(3):336-43. PubMed ID: 15922580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.
    Atkinson AJ; Lalonde RL
    Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal control strategy of malaria vector using genetically modified mosquitoes.
    Rafikov M; Bevilacqua L; Wyse AP
    J Theor Biol; 2009 Jun; 258(3):418-25. PubMed ID: 18761018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of parallel chemistry in drug discovery.
    Edwards PJ
    IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacognosy and reverse pharmacognosy: a new concept for accelerating natural drug discovery.
    Do QT; Bernard P
    IDrugs; 2004 Nov; 7(11):1017-27. PubMed ID: 15551177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resources, standards and tools for systems biology.
    Wierling C; Herwig R; Lehrach H
    Brief Funct Genomic Proteomic; 2007 Sep; 6(3):240-51. PubMed ID: 17942476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling iterative compound optimisation using a self-avoiding walk.
    Delaney J
    Drug Discov Today; 2009 Feb; 14(3-4):198-207. PubMed ID: 19027874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network models in drug discovery and regenerative medicine.
    Winkler DA
    Biotechnol Annu Rev; 2008; 14():143-70. PubMed ID: 18606362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.